Literature DB >> 15894756

Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies.

J M Morgan, J Marco, L Stockx, F Zannad.   

Abstract

The relationship between industry and clinicians in educational programmes needs to be regulated. Industry may be best placed to deliver educational programmes in "craft" related specialties and particularly in areas where device implantation/technology based therapy has a major clinical role. The authors supervise industry sponsored clinical teaching at a purpose built independent teaching facility, and have developed the concept of educational governance to regulate their relationship with their industry sponsor and that concept is presented.

Keywords:  Bioethics and Professional Ethics; Biomedical and Behavioral Research

Mesh:

Year:  2005        PMID: 15894756      PMCID: PMC1768959          DOI: 10.1136/hrt.2004.046839

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

1.  Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry.

Authors:  Paul A Komesaroff; Ian H Kerridge
Journal:  Med J Aust       Date:  2002-02-04       Impact factor: 7.738

2.  [Sponsorship, conflict of interest and corruption: promoting science in discussion of medical ethics].

Authors:  A Frewer
Journal:  Wien Med Wochenschr       Date:  2002

3.  Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.

Authors:  Allan S Brett; Wayne Burr; Jamaluddin Moloo
Journal:  Arch Intern Med       Date:  2003-10-13

4.  Sponsorship. No such thing as a free lunch?

Authors:  J Bryan
Journal:  Health Serv J       Date:  1995-10-19

5.  FDA issues draft 'concept paper' on drug company funding of CME.

Authors:  A Skolnick
Journal:  JAMA       Date:  1991-12-04       Impact factor: 56.272

Review 6.  Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.

Authors:  F Rosner
Journal:  Mt Sinai J Med       Date:  1995-11

7.  Continuing medical education in Europe: NVVC, CVOI, ESC, UEMS and EBAC.

Authors:  H R Michels
Journal:  Neth Heart J       Date:  2001-10       Impact factor: 2.380

8.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

9.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

10.  Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.

Authors:  M J Domanski; S Sakseena; A E Epstein; A P Hallstrom; M A Brodsky; S Kim; S Lancaster; E Schron
Journal:  J Am Coll Cardiol       Date:  1999-10       Impact factor: 24.094

View more
  1 in total

1.  SIR/RSNA/CIRSE Joint Medical Simulation Task Force strategic plan: executive summary.

Authors:  Derek Gould; Aalpen Patel; Gary Becker; Buddy Connors; John Cardella; Steven Dawson; Craig Glaiberman; David Kessel; Mick Lee; William Lewandowski; Roger Phillips; Jim Reekers; David Sacks; Marc Sapoval; Mark Scerbo
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Jul-Aug       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.